We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Progility | LSE:PGY | London | Ordinary Share | GB00BF5L3580 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 47.50 | 40.00 | 55.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
12/9/2017 14:18 | steady buying. | still waiting | |
12/9/2017 12:26 | brave being out. | still waiting | |
12/9/2017 11:40 | Still waiting - hi, I still hold a few here - not as many as I did, but 500k+ looking to buy a few more on weakness. Investigating crypto currencies taking more of my time. | dusseldorf | |
12/9/2017 11:39 | cyberbub - In theory Bos can name his own price, but my understanding (given volume of equity required) is that any motion to convert debt would have to be carried at general meeting by the independent shareholders (independent being the only parties not directly related to the transaction and the only ones eligible to vote). I certainly wouldn't vote for something at the wrong price. To be honest I'm not sure he wants to convert yet, he has another £20m ish? headroom in his finance facility. If the company is profitable, its profitable AFTER paying the finance fees for the loan he has provided (which is a nice little earner for him by the way). If he converted, the company profit jumps about £3m/year (as interest payments disappear) so the conversion process would have to reflect a fair market valuation for profit of £xm on turnover of £Ym - something the Nomad should also give an independent view on. My view is that the figure is 3-5p, however, it could be higher or lower dependent on when its done and how the business is performing. You can bet your bottom Aussie Dollar, that BOS will milk PGY for interest payments, whilst allowing it to expand, and fund it with new money - when the time is right, he'll convert and then sell it all at a big premium. | dusseldorf | |
12/9/2017 09:29 | That 301,328 paid 1.49p yesterday when 1.1-1.4p so they have bailed for 0.93p painful. I think if you are patient you will get another spike before results given how illiquid his stock is. | dave4545 | |
11/9/2017 21:38 | Might be worth looking at deal making credentials of Bos, if you applied market rates of interest to the borrowings and applied a growth pe to underlying earnings you'd get a completely different valuation. Now that the underlying businesses are profitable I'd like to see Bos reignite his deal making and transform this. A very quiet share this but it might just surprise a few when results released. Summary Mergers and acquisitions Specialties: Public and private company mergers and acquisitions, turnarounds and restructures in the technology, healthcare and renewable energy sectors An old city am article also gives some decent background on what he has done in the past. | still waiting | |
11/9/2017 21:25 | Just looking in here.Dusseldorf, if Bos essentially controls the company, and only sees PIs as the small liquidity to provide share price price-finding, surely it's hard to make an investment case here? You mentioned in earlier posts that Bos might convert his equity at 3p or 5p, but surely he can effectively name his own price, and it could just as easily be 1p, to further squeeze PIs down to essentially nothing and then buy them out?I am just doing a bit of research here, so forgive me if I have misunderstood anything. | cyberbub | |
11/9/2017 19:47 | Hi duss, Missed most of the action today, volumes rising nicely though. | still waiting | |
11/9/2017 17:01 | Still holding all mine, if all divisions are trading well and continued weakness in pound then results should confirm a decent base going forward. Still tightly held. | still waiting | |
11/9/2017 15:28 | Disappointing finish. Back to service as usual. But where there's smoke...?? | shrout | |
11/9/2017 15:23 | dave the price stalled before the rns. A few people taking positions ahead of results - I don't think you've seen the last spike prior to mid-October. I doubt they will issue another RNS again. | dusseldorf | |
11/9/2017 15:02 | No reason for rise Rns. So a share bounces from their lows and the company quickly puts the breaks on it. So what is the point of holding the stock if they spoil any rise unless it's a forced rns. | dave4545 | |
11/9/2017 13:10 | Strong break through 200 day SMA, solid results should underscore gains: | dusseldorf | |
11/9/2017 12:51 | I'm still in, what gives? I guess you could assume that FX (Weak pound) worked in favour in H1, that its going to work even more in favour of company in H2 given pound at near all time lows... | dusseldorf | |
11/9/2017 12:40 | Well done SW for keeping faith. Glad I clung on too when things were looking bleak. I hope this is start of a sustained rise now and not another false dawn. | shrout | |
11/9/2017 12:16 | I did say. | still waiting | |
08/9/2017 10:38 | With IoT in healthcare picking up pace a key change provider should benefit.. | still waiting | |
08/9/2017 10:34 | a bit tighter.. | still waiting | |
07/9/2017 14:45 | very tightly held so could see some action if results show continued improvement, now if Bos decides to be proactive? | still waiting | |
06/9/2017 09:17 | I still think this is one of the best candidates on aim for corporate action. £70m t/o, a controlling shareholder who has done deals in the past and a profitable underlying business.. let's see. | still waiting | |
05/9/2017 10:31 | could be blue this pm.. | still waiting | |
05/9/2017 10:00 | stops tested and hit with buys. results soon, looking for £75m t/o with an ebitda of £2.5m. ready for corporate action. too cheap down here imho. | still waiting | |
01/9/2017 08:22 | starting to wake up? after this many years it needs to. | still waiting |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions